血清甲状腺球蛋白对甲状腺乳头状癌肺叶切除术后结构复发的预测价值
本研究纳入2000-2014年间接受肺叶切除且血清Tg/ATg数据完整的甲状腺乳头状癌患者1451例,其中ATg阴性组1050例、ATg阳性组401例。结果显示ATg阴性组中血清Tg建立的分类器与复发关联良好(AUC=0.81),而ATg阳性组中血清ATg的AUC为0.72。首次Tg(术后6-12个月)和末次Tg的最佳截断值分别为5.3和11.0 ng/mL,Tg升高患者复发率显著更高。
要点
- 肺叶切除术后血清Tg对ATg阴性PTC患者复发预测价值良好(AUC=0.81)。
- 首次Tg最佳截断值5.3 ng/mL,末次Tg最佳截断值11.0 ng/mL。
- 首次Tg升高患者复发风险约为正常的2倍(HR=2.052)。
核心结论
- 肺叶切除术后血清Tg对PTC患者复发具有良好预测价值,合理阈值可识别随访中高复发风险患者。
研究设计与样本
- 回顾性研究,纳入2000-2014年间接受肺叶切除且血清Tg/ATg数据充足的PTC患者1451例。
- ATg阴性组1050例,ATg阳性组401例,采用随机森林建立复发预测分类器,并用ROC曲线确定截断值。
主要发现
- ATg阴性组66例(6.3%)复发,ATg阳性组26例(6.5%)复发。
- ATg阴性组血清Tg分类器与复发关联良好(AUC=0.81),血清ATg分类器AUC=0.72。
- 首次Tg和末次Tg最佳截断值分别为5.3和11.0 ng/mL。
- 末次Tg升高患者复发率显著高于正常者(23.5% vs. 4.4%,p<0.05)。
- 首次Tg升高患者在全部ATg阴性、低危、中高危组中无复发生存率均显著更低(n=1050、583、467,均p<0.05)。
关键数值与推荐
- 首次Tg(术后6-12个月测量)最佳截断值5.3 ng/mL。
- 末次Tg(最近一次测量)最佳截断值11.0 ng/mL。
- 首次Tg升高者复发风险HR=2.052。
临床怎么用
- 对肺叶切除术后PTC患者,尤其ATg阴性者,可用血清Tg进行复发风险分层。
- 首次Tg(术后6-12个月)超过5.3 ng/mL或末次Tg超过11.0 ng/mL提示复发风险较高,需加强随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: The value of serum thyroglobulin/antithyroglobulin (Tg/antithyroglobulin antibody [ATg]) for papillary thyroid carcinoma (PTC) surveillance after lobectomy was investigated. We aimed to examine the association between postlobectomy serum Tg/ATg and PTC structural recurrence and define applicable values for stratification. Methods: PTC patients who underwent lobectomy with adequate serum Tg/ATg data during 2000-2014 were selected. Predictive classifiers of recurrence using random forest were established combining different variables related to serum Tg (ATg-negative patients) or ATg (ATg-positive patients). Cutoff values were determined with receiver operating characteristic curves when applicable. Kaplan-Meier curve and Cox regression were performed to examine the predictive value of elevated Tg/ATg. Results: Of 1451 patients enrolled, 66 (6.3%) and 26 (6.5%) patients in the ATg-negative group (n = 1050) and ATg-positive group (n = 401) developed recurrence. The established classifier of serum Tg (n = 1050) showed a favorable association with recurrence (AUC = 0.81), while serum ATg did not (AUC = 0.72). The optimal cutoff values of the first Tg (FTg, measured 6-12 months after lobectomy) and last Tg (LTg, measured most recently) were 5.3 and 11.0 ng/mL, respectively. Elevated LTg patients had significantly higher recurrence rates than normal LTg patients (23.5% vs. 4.4%, p < 0.05). Patients with elevated FTg had significantly lower recurrence-free survival rates than patients with normal FTg in all ATg-negative patients, low-risk patients, and intermediate- to high-risk patients (according to the American Thyroid Association initial risk stratification) (n = 1050, 583, and 467, all p < 0.05). Multivariate analysis indicated patients with elevated FTg had twice the recurrent risk compared with those with normal FTg (hazard ratio = 2.052). Conclusions: Postlobectomy serum Tg has favorable value for predicting recurrence in PTC patients, and reasonable thresholds could identify patients at higher risk for recurrence during follow-up.
引用
- Xu S, Huang H, Zhang X, et al. Predictive Value of Serum Thyroglobulin for Structural Recurrence Following Lobectomy for Papillary Thyroid Carcinoma. Thyroid. 2021. PMID: 34340593. doi:10.1089/thy.2021.0209
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。